Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 55Recruiting 25Unknown 16Active not recruiting 9Not yet recruiting 5Withdrawn 3Terminated 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 33Breast Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Lung Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Colonic Neoplasms 6Brain Neoplasms 6Pain 5Epilepsy 5Depression 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Inflammation 4Head and Neck Neoplasms 4Dementia 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Motor Activity 3Lymphedema 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Cognitive Dysfunction × Clear all
NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Cognito Therapeutics, Inc.

Phase NA Enrolling by invitation
402 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡